Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-01-04

FDA Approved: LISINOPRIL — Supplemental Application (Solco healthcare U.S., LLC)

View source ↗

Summary

FDA approved a supplemental application for lisinopril from Solco Healthcare U.S., LLC, supporting continued availability of the generic ACE inhibitor.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lisinopril (Lisinopril)

Snippet

SUPPL AP for LISINOPRIL (LISINOPRIL)